DiaMedica Therapeutics Inc (NASDAQ:DMAC)

4.24
Delayed Data
As of 3:59pm ET
 +0.18 / +4.43%
Today’s Change
1.70
Today|||52-Week Range
8.80
-12.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.00500.0K
 
 
Depreciation And Amortization4.5K2.2K3.5K15.0K
 
 
 
 
 
 
Operating ExpensesGross Income-4.5K-2.2K-3.5K--
 
 
 
 
General Expenses1.4M2.5M4.4M6.9M
 
 
 
 
 
Research And Development956.6K1.8M3.5M4.5M
 
 
 
 
 
Total Operating Expenses1.4M2.5M4.4M6.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.4M-2.5M-4.4M-6.4M
 
 
 
 
 
Extraordinary Credit0.000.0093.6K0.00
 
 
Extraordinary Charge0.000.00---399.0K
 
 
Interest Expense On Debt47.7K52.7K4.8K0.00
 
 
 
 
Other Expenses-85.1K331.6K168.1K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-2.2M-4.1M-5.7M
 
 
 
 
 
Income Taxes-13.5K-22.3K-34.3K-80.0K
 
 
 
 
 
Net Income-1.6M-2.2M-4.2M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.6M4.7M5.9M7.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.6M4.7M5.9M7.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.40-$0.80-$0.74
 
 
 
 
 
EPS Diluted-$0.47-$0.40-$0.80-$0.74